2024 Q3 Form 10-Q Financial Statement

#000165495424010589 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $4.696M $4.676M $4.713M
YoY Change -1.4% -0.79% 9.63%
Cost Of Revenue $2.515M $2.431M $2.325M
YoY Change 9.51% 4.59% 2.75%
Gross Profit $2.181M $2.244M $2.388M
YoY Change -11.56% -6.02% 17.27%
Gross Profit Margin 46.44% 48.0% 50.67%
Selling, General & Admin $1.818M $1.718M $1.600M
YoY Change 11.11% 7.37% 4.7%
% of Gross Profit 83.36% 76.54% 66.99%
Research & Development $771.3K $787.1K $684.0K
YoY Change 6.31% 15.07% 27.88%
% of Gross Profit 35.37% 35.07% 28.64%
Depreciation & Amortization $775.0K $752.1K $643.7K
YoY Change 15.66% 16.84% 25.57%
% of Gross Profit 35.54% 33.51% 26.95%
Operating Expenses $2.589M $2.505M $2.284M
YoY Change 9.64% 9.68% 10.71%
Operating Profit -$408.4K -$260.4K $104.3K
YoY Change -492.14% -349.79% -492.46%
Interest Expense $76.00 $419.00 $404.00
YoY Change -99.62% 3.71% -20.32%
% of Operating Profit 0.39%
Other Income/Expense, Net $9.996K -$30.48K
YoY Change -132.8% -77.55%
Pretax Income -$440.2K -$250.4K $73.79K
YoY Change -447.23% -439.41% -145.46%
Income Tax $738.00 -$730.00 $752.00
% Of Pretax Income 1.02%
Net Earnings -$440.9K -$251.2K $73.04K
YoY Change -449.85% -443.9% -144.79%
Net Earnings / Revenue -9.39% -5.37% 1.55%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 90.48M shares 90.48M shares 90.48M shares
Diluted Shares Outstanding 90.48M shares 90.48M shares 121.0M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $291.2K $232.7K $740.1K
YoY Change -64.49% -68.55% -16.87%
Cash & Equivalents $291.2K $232.7K $740.1K
Short-Term Investments
Other Short-Term Assets $151.7K $132.2K $106.9K
YoY Change 75.01% 23.69% 547.46%
Inventory
Prepaid Expenses $211.7K $218.6K $227.8K
Receivables $1.077M $1.250M $875.1K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.732M $1.834M $1.950M
YoY Change -17.4% -5.95% 4.33%
LONG-TERM ASSETS
Property, Plant & Equipment $235.3K $261.6K $4.553M
YoY Change -95.02% -94.26% 20.13%
Goodwill $110.0K $110.0K $110.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles $53.97K $56.57K $69.60K
YoY Change -20.18% -18.73% -10.24%
Long-Term Investments
YoY Change
Other Assets $17.54K $16.40K $15.35K
YoY Change -12.3% 6.84% -72.34%
Total Long-Term Assets $5.658M $5.570M $5.160M
YoY Change 5.38% 7.95% 11.46%
TOTAL ASSETS
Total Short-Term Assets $1.732M $1.834M $1.950M
Total Long-Term Assets $5.658M $5.570M $5.160M
Total Assets $7.390M $7.404M $7.110M
YoY Change -1.02% 4.14% 9.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.849M $2.532M $2.176M
YoY Change 29.48% 16.4% -13.77%
Accrued Expenses $186.0K $204.7K $173.2K
YoY Change -7.01% 18.19% -7.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.062M $4.602M $3.879M
YoY Change 24.17% 18.64% -7.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $767.2K
YoY Change -100.0% -100.0% 30.6%
Other Long-Term Liabilities $311.1K $343.6K $522.0K
YoY Change -49.0% -34.18% 21.99%
Total Long-Term Liabilities $311.1K $343.6K $1.289M
YoY Change -76.43% -73.35% 26.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.062M $4.602M $3.879M
Total Long-Term Liabilities $311.1K $343.6K $1.289M
Total Liabilities $5.373M $4.946M $5.168M
YoY Change -0.49% -4.3% -0.77%
SHAREHOLDERS EQUITY
Retained Earnings -$20.58M -$20.14M -$20.04M
YoY Change 3.37% 0.52% -3.12%
Common Stock $90.48K $90.48K $90.48K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.017M $2.458M -$1.042M
YoY Change
Total Liabilities & Shareholders Equity $7.390M $7.404M $7.110M
YoY Change -1.02% 4.14% 9.41%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$440.9K -$251.2K $73.04K
YoY Change -449.85% -443.9% -144.79%
Depreciation, Depletion And Amortization $775.0K $752.1K $643.7K
YoY Change 15.66% 16.84% 25.57%
Cash From Operating Activities $973.2K $874.4K $882.2K
YoY Change 4.65% -0.88% -30.0%
INVESTING ACTIVITIES
Capital Expenditures $914.7K $886.0K $817.2K
YoY Change 7.62% 8.42% -206.84%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$914.7K -$886.0K -$817.2K
YoY Change 7.62% 8.42% 6.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 973.2K 874.4K 882.2K
Cash From Investing Activities -914.7K -886.0K -817.2K
Cash From Financing Activities 0.000
Net Change In Cash 58.49K -11.55K 65.03K
YoY Change -26.89% -117.76% -86.86%
FREE CASH FLOW
Cash From Operating Activities $973.2K $874.4K $882.2K
Capital Expenditures $914.7K $886.0K $817.2K
Free Cash Flow $58.49K -$11.55K $65.03K
YoY Change -26.89% -117.76% -96.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1154787 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
133478 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1735210 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16850 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1250482 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
218552 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
132176 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
1833945 usd
CY2024Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
16404 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
261551 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4602261 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3873460 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-888057 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56570 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
292047 usd
CY2024Q2 us-gaap Assets
Assets
7403776 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2210933 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
206146 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
90479 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
90479 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19523795 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18910482 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20140191 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19860842 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2457940 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
262113 usd
us-gaap Revenues
Revenues
9463025 usd
CY2023Q2 qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
2499900 usd
CY2024Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
258676 usd
CY2024Q2 us-gaap Goodwill
Goodwill
110000 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2532243 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1865332 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1456381 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
204686 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
84899 usd
CY2024Q2 qmci Preferred Stock Warrant Liability
PreferredStockWarrantLiability
0 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001101433
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Security12b Title
Security12bTitle
Common stock, par value $.001 per share
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90477798 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90477798 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90477798 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
123685 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
123685 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
123685 shares
CY2023Q4 qmci Convertible Preferred Stock Designated
ConvertiblePreferredStockDesignated
550000 shares
CY2024Q2 qmci Stock Options And Warrants To Purchase Common Stock
StockOptionsAndWarrantsToPurchaseCommonStock
0 shares
qmci Stock Options And Warrants To Purchase Common Stock
StockOptionsAndWarrantsToPurchaseCommonStock
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-28599
dei Entity Registrant Name
EntityRegistrantName
QuoteMedia, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-2008633
dei Entity Address Address Line1
EntityAddressAddressLine1
17100 East Shea Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
dei Entity Address City Or Town
EntityAddressCityOrTown
Fountain Hills
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85268
dei City Area Code
CityAreaCode
602
dei Local Phone Number
LocalPhoneNumber
830-1443
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
90477798 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232735 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
342014 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
104931 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
302224 usd
CY2024Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4833259 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4552910 usd
CY2023Q4 us-gaap Goodwill
Goodwill
110000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
65636 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
393472 usd
CY2023Q4 us-gaap Assets
Assets
7176302 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
375568 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
191735 usd
CY2023Q4 qmci Preferred Stock Warrant Liability
PreferredStockWarrantLiability
611563 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
343575 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1178866 usd
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
123685 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
2983857 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-859881 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7403776 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7176302 usd
CY2024Q2 us-gaap Revenues
Revenues
4675946 usd
CY2023Q2 us-gaap Revenues
Revenues
4712977 usd
us-gaap Revenues
Revenues
9355146 usd
us-gaap Revenues
Revenues
9463025 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
2431460 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
2324798 usd
us-gaap Cost Of Revenue
CostOfRevenue
4773574 usd
us-gaap Cost Of Revenue
CostOfRevenue
4644733 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
2244486 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2388179 usd
us-gaap Gross Profit
GrossProfit
4581572 usd
us-gaap Gross Profit
GrossProfit
4818292 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
857524 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
829712 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1634726 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1653765 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
860327 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
770187 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1668681 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1622701 usd
CY2024Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
787074 usd
CY2023Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
684015 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1590396 usd
us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
1314088 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2504925 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2283914 usd
us-gaap Operating Expenses
OperatingExpenses
4893803 usd
us-gaap Operating Expenses
OperatingExpenses
4590554 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-260439 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
104265 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-312231 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
227738 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
10415 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-30073 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
35722 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-38074 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
419 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
404 usd
us-gaap Interest Expense
InterestExpense
1372 usd
us-gaap Interest Expense
InterestExpense
1856 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9996 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30477 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34350 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-39930 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-250443 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73788 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-277881 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
187808 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-730 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-752 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1468 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1482 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-251173 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
73036 usd
us-gaap Net Income Loss
NetIncomeLoss
-279349 usd
us-gaap Net Income Loss
NetIncomeLoss
186326 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121000418 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120876073 shares
CY2024Q2 qmci Reclassification Of Preferred Stock Warrants
ReclassificationOfPreferredStockWarrants
611563 usd
CY2024Q2 qmci Reclassification Of Series A Redeemable Convertible Preferred Stock Amount
ReclassificationOfSeriesARedeemableConvertiblePreferredStockAmount
2983857 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1750 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-251173 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2457940 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-859881 usd
qmci Reclassification Of Preferred Stock Warrants
ReclassificationOfPreferredStockWarrants
611563 usd
qmci Reclassification Of Series A Redeemable Convertible Preferred Stock Amount
ReclassificationOfSeriesARedeemableConvertiblePreferredStockAmount
2983857 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1750 usd
us-gaap Net Income Loss
NetIncomeLoss
-279349 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2457940 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1115385 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
73036 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1042349 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1228675 usd
us-gaap Net Income Loss
NetIncomeLoss
186326 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1042349 usd
us-gaap Profit Loss
ProfitLoss
-279349 usd
us-gaap Profit Loss
ProfitLoss
186326 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1480760 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1271683 usd
qmci Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
350000 usd
qmci Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
125000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1750 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
qmci Stock Based Compensation Preferred Stock
StockBasedCompensationPreferredStock
0 usd
qmci Stock Based Compensation Preferred Stock
StockBasedCompensationPreferredStock
137813 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
445695 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
89853 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
85074 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3863 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
27245 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
77772 usd
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
446 usd
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-351 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
314439 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-324580 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
292059 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
642450 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1602091 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1874579 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28655 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37120 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1682715 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1575346 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1711370 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1612466 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-109279 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
342014 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477987 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232735 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
740100 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
225000 usd
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
25852 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-38241 usd
CY2024Q2 us-gaap Revenues
Revenues
4675946 usd
CY2023Q2 us-gaap Revenues
Revenues
4712977 usd
us-gaap Revenues
Revenues
9355146 usd
qmci Deferred Revenue At Beginning Balance
DeferredRevenueAtBeginningBalance
1831949 usd
qmci Deferred Revenue At Beginning Balance
DeferredRevenueAtBeginningBalance
1166848 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
1105335 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
868395 usd
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
1381619 usd
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
1507660 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
15775 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
3185 usd
qmci Deferred Revenue At Ending Balance
DeferredRevenueAtEndingBalance
2124008 usd
qmci Deferred Revenue At Ending Balance
DeferredRevenueAtEndingBalance
1809298 usd
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1865332 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1530329 usd
CY2024Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
258676 usd
CY2023Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
278969 usd
CY2024Q2 us-gaap Deferred Revenue
DeferredRevenue
2124008 usd
CY2023Q2 us-gaap Deferred Revenue
DeferredRevenue
1809298 usd
us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
lease terms of 1 year to 3 years
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
292047 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
393472 usd
CY2024Q2 qmci Current Portion Of Operating Lease Liability
CurrentPortionOfOperatingLeaseLiability
204686 usd
CY2023Q4 qmci Current Portion Of Operating Lease Liability
CurrentPortionOfOperatingLeaseLiability
206146 usd
CY2024Q2 qmci Long Term Portion Of Operating Lease Liability
LongTermPortionOfOperatingLeaseLiability
84899 usd
CY2023Q4 qmci Long Term Portion Of Operating Lease Liability
LongTermPortionOfOperatingLeaseLiability
191735 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
289585 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
397881 usd
qmci Operating Lease Weighted Average Remaining Lease Term
OperatingLeaseWeightedAverageRemainingLeaseTerm
P1Y6M
CY2023 qmci Operating Lease Weighted Average Remaining Lease Term
OperatingLeaseWeightedAverageRemainingLeaseTerm
P1Y10M24D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095 pure
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
114182 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
163272 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
33861 usd
CY2024Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
311315 usd
CY2024Q2 qmci Less Imputed Interest Operating
LessImputedInterestOperating
-21730 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
289585 usd
CY2024Q2 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
58969 usd
CY2023Q2 us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
59165 usd
us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
118010 usd
us-gaap Operating Lease Initial Direct Cost Expense Over Term
OperatingLeaseInitialDirectCostExpenseOverTerm
117592 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
27338 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
26993 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
54674 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
53980 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
86307 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
86158 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
172684 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
171572 usd
qmci Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
115146 usd
qmci Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
116784 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
1750 usd
CY2023Q2 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
0 usd
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
1750 usd
us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
0 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1750 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1750 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2024Q2 qmci Expected Dividend Yield
ExpectedDividendYield
0 pure
qmci Expected Dividend Yield
ExpectedDividendYield
0 pure
CY2024Q2 qmci Expected Stock Price Volatility
ExpectedStockPriceVolatility
0.76 pure
qmci Expected Stock Price Volatility
ExpectedStockPriceVolatility
0.76 pure
CY2024Q2 qmci Risk Free Interest Rate
RiskFreeInterestRate
0.04 pure
qmci Risk Free Interest Rate
RiskFreeInterestRate
0.04 pure
CY2024Q2 qmci Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm
P2Y6M
qmci Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm
P2Y6M
CY2024Q2 qmci Weighted Average Fair Value Of Options And Warrants Granted
WeightedAverageFairValueOfOptionsAndWarrantsGranted
0.17
qmci Weighted Average Fair Value Of Options And Warrants Granted
WeightedAverageFairValueOfOptionsAndWarrantsGranted
0.17
CY2023 qmci Expected Time To Expiration Years
ExpectedTimeToExpirationYears
P24Y18D
CY2023 qmci Stock Price On Valuation Date
StockPriceOnValuationDate
0.23
CY2023 qmci Five Year Peer Volatility
FiveYearPeerVolatility
0.4735 pure
CY2023 qmci Cash Flow Discount Rate
CashFlowDiscountRate
0.1586 pure
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-251173 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
73036 usd
us-gaap Net Income Loss
NetIncomeLoss
-279349 usd
us-gaap Net Income Loss
NetIncomeLoss
186326 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
90477798 shares
CY2024Q2 qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
0 usd
qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
0 usd
qmci Warrants To Purchase Redeemable Convertible Preferred Stock
WarrantsToPurchaseRedeemableConvertiblePreferredStock
2499900 usd
CY2024Q2 qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
0 usd
CY2023Q2 qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
10306671 usd
qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
0 usd
qmci Redeemable Convertible Preferred Stock
RedeemableConvertiblePreferredStock
10306671 usd
CY2023Q2 qmci Stock Options And Warrants To Purchase Common Stock
StockOptionsAndWarrantsToPurchaseCommonStock
17716049 shares
qmci Stock Options And Warrants To Purchase Common Stock
StockOptionsAndWarrantsToPurchaseCommonStock
17591704 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121000418 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90477798 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120876073 shares
CY2023Q2 qmci Earningspersharebasic
Earningspersharebasic
0.00
qmci Earningspersharebasic
Earningspersharebasic
-0.00
qmci Earningspersharebasic
Earningspersharebasic
0.00
CY2024Q2 qmci Earningspersharediluted
Earningspersharediluted
-0.00
CY2023Q2 qmci Earningspersharediluted
Earningspersharediluted
0.00
qmci Earningspersharediluted
Earningspersharediluted
-0.00
qmci Earningspersharediluted
Earningspersharediluted
0.00
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29177063 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29358001 shares

Files In Submission

Name View Source Status
0001654954-24-010589-index-headers.html Edgar Link pending
0001654954-24-010589-index.html Edgar Link pending
0001654954-24-010589.txt Edgar Link pending
0001654954-24-010589-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qmci-20240630.xsd Edgar Link pending
qmci_10q.htm Edgar Link pending
qmci_ex311.htm Edgar Link pending
qmci_ex321.htm Edgar Link pending
qmci_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
qmci-20240630_cal.xml Edgar Link unprocessable
qmci-20240630_def.xml Edgar Link unprocessable
qmci-20240630_pre.xml Edgar Link unprocessable
qmci-20240630_lab.xml Edgar Link unprocessable
qmci_10q_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable